Markus Schlaich

Hivatkozott rá

	Összes	2019 óta
Hivatkozások	56296	31360
h-index	97	67
i10-index	329	260

9000

4500

2250

6750

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024190 205 191 226 326 383 481 622 1090 1987 3231 3800 3460 2987 2493 2258 2419 2649 4163 5916 7042 8890

Nyilvános hozzáférés

Összes megtekintése

189 cikk

70 cikk

elérhető

nem érhető el

Finanszírozási megbízások alapján

Társszerzők

Murray EslerSenior Director Baker IDI Heart and Diabetes InstituteE-mail megerősítve itt: bakeridi.edu.au
Elisabeth LambertAssociate Professor, Swinburne University of TechnologyE-mail megerősítve itt: swin.edu.au
Felix MahfoudSaarland UniversityE-mail megerősítve itt: uniklinikum-saarland.de
Nina EikelisIverson Health Innovation Research Institute, Swinburne University of TechnologyE-mail megerősítve itt: swin.edu.au
Paul A SobotkaE-mail megerősítve itt: alumni.stanford.edu
Aletta E SchutteUniversity of New South Wales/George Institute for Global HealthE-mail megerősítve itt: unsw.edu.au
Antony S WaltonAlfred HospitalE-mail megerősítve itt: wh.org.au
Bryan WilliamsUniversity College LondonE-mail megerősítve itt: ucl.ac.uk
George StergiouNational and Kapodistrian University of Athens, Medical SchoolE-mail megerősítve itt: med.uoa.gr
John DixonIverson Health Innovation Research Institute, Swinburne University of Technology, MelbourneE-mail megerősítve itt: swin.edu.au
Lakshini HeratRPH Research Foundation FellowE-mail megerősítve itt: uwa.edu.au
Giuseppe ManciaEmeritus Professor, Università Bicocca - Milan ITALYE-mail megerősítve itt: UNIMIB.IT
Borghi ClaudioProfessor of Medicine-University of Bologna, Bologna-ItalyE-mail megerősítve itt: unibo.it
Christian DellesUniversity of GlasgowE-mail megerősítve itt: glasgow.ac.uk
Thomas UngerDirector CARIM, Maastricht UniversityE-mail megerősítve itt: maastrichtuniversity.nl
Clive N MayProfessor, Preclinical Critical Care Unit, Florey Institute of Neuroscience and Mental HealthE-mail megerősítve itt: florey.edu.au
Garry JenningsBaker Heart and Diabetes InstituteE-mail megerősítve itt: baker.edu.au
Mark NelsonUniversity of TasmaniaE-mail megerősítve itt: utas.edu.au
Lindsea C BoothFlorey InstituteE-mail megerősítve itt: florey.edu.au
Professor Kate M DentonHead, Cardiovascular Disease Program, Monash Biomedical Discovery InstituteE-mail megerősítve itt: monash.edu

Követés

Markus Schlaich

Dobney Hypertension Centre - Royal Perth Hospital Campus, University of Western Australia

E-mail megerősítve itt: uwa.edu.au

sympathetic nervous system hypertension chronic kidney disease renal denervation


Cím Rendezés hivatkozások szerint Rendezés év szerint Rendezés cím szerint	Hivatkozott rá Hivatkozott rá	Év
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020	6908	2020
2020 International Society of Hypertension global hypertension practice guidelines T Unger, C Borghi, F Charchar, NA Khan, NR Poulter, D Prabhakaran, ... Hypertension 75 (6), 1334-1357, 2020	4584	2020
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study H Krum, M Schlaich, R Whitbourn, PA Sobotka, J Sadowski, K Bartus, ... The Lancet 373 (9671), 1275-1281, 2009	3246	2009
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Symplicity HTN-2 Investigators The Lancet 376 (9756), 1903-1909, 2010	3222	2010
Global, regional, and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 VL Feigin, BA Stark, CO Johnson, GA Roth, C Bisignano, GG Abady, ... The Lancet Neurology 20 (10), 795-820, 2021	2244	2021
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023	1357	2023
Renal sympathetic-nerve ablation for uncontrolled hypertension MP Schlaich, PA Sobotka, H Krum, E Lambert, MD Esler New England Journal of Medicine 361 (9), 932-934, 2009	1258	2009
Stenting and medical therapy for atherosclerotic renal-artery stenosis CJ Cooper, TP Murphy, DE Cutlip, K Jamerson, W Henrich, DM Reid, ... New England Journal of Medicine 370 (1), 13-22, 2014	1135	2014
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study F Mahfoud, M Schlaich, I Kindermann, C Ukena, B Cremers, MC Brandt, ... Circulation 123 (18), 1940-1946, 2011	900	2011
Renin-angiotensin system and cardiovascular risk RE Schmieder, KF Hilgers, MP Schlaich, BMW Schmidt The Lancet 369 (9568), 1208-1219, 2007	899	2007
Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study H Krum, MP Schlaich, PA Sobotka, M Böhm, F Mahfoud, K Rocha-Singh, ... The Lancet 383 (9917), 622-629, 2014	821	2014
Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation MP Schlaich, E Lambert, DM Kaye, Z Krozowski, DJ Campbell, G Lambert, ... Hypertension 43 (2), 169-175, 2004	790	2004
Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy MP Schlaich, DM Kaye, E Lambert, M Sommerville, F Socratous, MD Esler Circulation 108 (5), 560-565, 2003	702	2003
Renal sympathetic denervation for treatment of drug-resistant hypertension: one-year results from the Symplicity HTN-2 randomized, controlled trial MD Esler, H Krum, M Schlaich, RE Schmieder, M Böhm, PA Sobotka Circulation 126 (25), 2976-2982, 2012	638	2012
Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension F Mahfoud, B Cremers, J Janker, B Link, O Vonend, C Ukena, D Linz, ... Hypertension 60 (2), 419-424, 2012	619	2012
Sympathetic activation in chronic renal failure MP Schlaich, F Socratous, S Hennebry, N Eikelis, EA Lambert, ... Journal of the American Society of Nephrology 20 (5), 933-939, 2009	566	2009
Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept MP Schlaich, PA Sobotka, H Krum, R Whitbourn, A Walton, MD Esler Hypertension 54 (6), 1195-1201, 2009	559	2009
Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension F Mahfoud, C Ukena, RE Schmieder, B Cremers, LC Rump, O Vonend, ... Circulation 128 (2), 132-140, 2013	510	2013
Renal denervation in moderate to severe CKD D Hering, F Mahfoud, AS Walton, H Krum, GW Lambert, EA Lambert, ... Journal of the American Society of Nephrology 23 (7), 1250-1257, 2012	482	2012
Relevance of sympathetic nervous system activation in obesity and metabolic syndrome AA Thorp, MP Schlaich Journal of diabetes research 2015 (1), 341583, 2015	468	2015

A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.

Cikkek 1–20

Hivatkozások évente

Ismétlődő hivatkozások

Összevont hivatkozások

Társszerzők hozzáadásaTársszerzők

Követés

Hivatkozott rá

Társszerzők